Search Results
"Targeting Residual Risk for the Prevention of Atherosclerotic CV Disease" by Imran Rashid, MD
Eckel Invited Lecture: Evaluating and Treating "Residual Risk" in ASCVD | Michael J. Blaha, MD, MPH
Methotrexate didn't deliver cardiovascular prevention benefits
Grand Rounds 2021.02.24
Low dose Methotrexate for the Prevention of Atherosclerotic Events
Grand Rounds Cardiovascular -Optimal Anti-Platelet and Anti-Coagulant Strategies in Atherothrombosis
Post-PCI Medical Management - Dr. Deepak L. Bhatt
CGR- Dr. Rita Redberg, 9/29
Antisense Strategies Against Non-Liver Targets
Are All Your Medications Good for You? (Full Lecture)
